Company news

Galectin Therapeutics Inc. news in 2020

Galectin Therapeutics Inc.'s news releases, calls and decks from 2020, newest first.

View company

Galectin Therapeutics, Inc. to Present at the 4th Annual Digital NASH Summit on December 17, 2020

December 10, 2020

Galectin Therapeutics Inc. Recaps Results of Annual Meeting of Stockholders Presentation

December 3, 2020

Galectin Therapeutics to Webcast Corporate Update on December 3, 2020 after Annual Meeting of Stockholders

November 30, 2020

Galectin Therapeutics Provides Business Update And Reports Financial Results for the Quarter Ended September 30, 2020

November 8, 2020

Galectin Therapeutics Investor Conference Call and Webinar Taking Place Today

September 28, 2020

Galectin Therapeutics Announces Investor Conference Call and Webinar on September 29, 2020

September 21, 2020

Galectin Therapeutics Inc. to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 14, 2020

September 9, 2020

Galectin Therapeutics Appoints Joel Lewis as Chief Executive Officer

September 1, 2020

Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2020, and Provides Business Update

August 9, 2020

Galectin Therapeutics Announces Commencement of Patient Enrollment of the Adaptively-Designed Phase 2b/3 Trial of Belapectin in NASH Cirrhosis

June 29, 2020

Galectin Therapeutics Reports Financial Results for the Quarter Ended March 31, 2020, and Provides Business Update

May 10, 2020

Galectin Therapeutics Submits Seamless Adaptively-Designed Phase 2b/3 NASH-RX Protocol in NASH Cirrhosis

April 29, 2020

Galectin Therapeutics Update on the Impact of COVID-19

April 1, 2020

Galectin Therapeutics Reports Fiscal 2019 Financial Results and Provides Business Update

March 15, 2020

Galectin Therapeutics Appoints Seasoned Biopharmaceutical Executive Pol F. Boudes, M.D. as Chief Medical Officer

February 19, 2020

Decks in 2020